Previous close | 0.2000 |
Open | 0.2000 |
Bid | 0.0000 |
Ask | 1.3500 |
Strike | 160.00 |
Expiry date | 2025-01-17 |
Day's range | 0.1500 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | 15 |
The FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat adults with familial chylomicronemia syndrome. A final decision is expected in December 2024.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.